Halozyme Therapeutics (NASDAQ:HALO) Q3 2026 Earnings Call
Halozyme Therapeutics (NASDAQ:HALO) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Halozyme Therapeutics, Inc. (NASDAQ:HALO)
- Period
- Q3 2026 earnings call
- Date
- Thu, Nov 5, 2026, 4:30 PM ET
On 6ix: 6ix.com/event/halozyme-therapeutics-inc-halo-q3-2026-earnings-call
Latest news releases
- NASDAQ:HALO — Halozyme to Report Third Quarter 2026 Financial and Operating Results · Thu, Oct 22, 2026
- NASDAQ:HALO — Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets · Wed, Oct 7, 2026